Kiromic Deadline Alert - Kiromic BioPharma (NASDAQ:KRBP) - Benzinga

Retrieved on: 2022-10-03 00:59:33

Tags for this article:

Financial markets

U.S. Securities and Exchange Commission

73rd United States Congress

Securities Act

Securities regulation in the United States

Securities Class Action

Prospectus

Security

Food and Drug Administration

Health

Financial economics

FARUQI & FARUQI LLP

Kiromic BioPharma Inc.

Click the tags to see associated articles and topics

Kiromic Deadline Alert - Kiromic BioPharma (NASDAQ:KRBP) - Benzinga. View article details on HISWAI: https://www.benzinga.com/pressreleases/22/10/29110736/kiromic-deadline-alert

Excerpt

October 2, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Kiromic BioPharma, ...

Article found on: www.benzinga.com

View Original Article